Immunological and functional features of decellularized xenogeneic heart valves after transplantation into GGTA1-KO pigs.
Robert RammTobias GoeckePeter KöhlerIgor TudoracheSerghei CebotariAnatol CiubotaruSamir SarikouchKlaus HöfflerFriederike BotheBjörn PetersenAxel HaverichHeiner NiemannAndres HilfikerPublished in: Regenerative biomaterials (2021)
Decellularization of xenogeneic heart valves might lead to excellent regenerative implants, from which many patients could benefit. However, this material carries various xenogeneic epitopes and thus bears a considerable inherent immunological risk. Here, we investigated the regenerative and immunogenic potential of xenogeneic decellularized heart valve implants using pigs deficient for the galactosyltransferase gene (GGTA1-KO) as novel large animal model. Decellularized aortic and pulmonary heart valves obtained from sheep, wild-type pigs or GGTA1-KO pigs were implanted into GGTA1-KO pigs for 3, or 6 months, respectively. Explants were analyzed histologically, immunhistologically (CD3, CD21 and CD172a) and anti-αGal antibody serum titers were determined by ELISA. Xenogeneic sheep derived implants exhibited a strong immune reaction upon implantation into GGTA1-KO pigs, characterized by massive inflammatory cells infiltrates, presence of foreign body giant cells, a dramatic increase of anti-αGal antibody titers and ultimately destruction of the graft, whereas wild-type porcine grafts induced only a mild reaction in GGTA1-KO pigs. Allogeneic implants, wild-type/wild-type and GGTA1-KO/GGTA1-KO valves did not induce a measurable immune reaction. Thus, GGTA1-KO pigs developed a 'human-like' immune response toward decellularized xenogeneic implants showing that immunogenicity of xenogeneic implants is not sufficiently reduced by decellularization, which detracts from their regenerative potential.
Keyphrases
- wild type
- aortic valve
- stem cells
- tissue engineering
- heart failure
- immune response
- mesenchymal stem cells
- induced apoptosis
- aortic valve replacement
- extracellular matrix
- cell therapy
- endothelial cells
- oxidative stress
- pulmonary hypertension
- ejection fraction
- end stage renal disease
- coronary artery
- stem cell transplantation
- bone marrow
- cell cycle arrest
- newly diagnosed
- gene expression
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- aortic stenosis
- genome wide
- dendritic cells
- high glucose
- induced pluripotent stem cells
- prognostic factors
- signaling pathway